KLRK1 and neoplasm: In contrast, tumors treated with NKG2D CAR-T cells progressively decreased and gradually shrank to disappearance, with no tumor recurrence observed until day 62 after tumor implantation, the longest time point monitored in the experiment (Figures 4B–D).